This article was originally published in The Gray Sheet
Executive SummaryFirm preparing response to Feb. 7 questions by FDA on March 2000 PMA supplement for the LaserScan LSX for treatment of astigmatism using photorefractive keratectomy. In December, the firm filed a separate PMA supplement for LASIK treatment of myopia and myopic astigmatism
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.